Enanta Pharmaceuticals Ownership | Who Owns Enanta Pharmaceuticals?
Enanta Pharmaceuticals Ownership Summary
Enanta Pharmaceuticals is owned by 125.09% institutional investors, 4.68% insiders. Janus henderson group is the largest institutional shareholder, holding 17.70% of ENTA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.95% of its assets in Enanta Pharmaceuticals shares.
ENTA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Enanta Pharmaceuticals | 125.09% | 4.68% | -29.78% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Janus henderson group | 3.78M | 17.70% | $47.72M |
| Blackrock funding, inc. /de | 3.10M | 14.52% | $39.20M |
| Farallon capital management | 2.87M | 13.43% | $36.27M |
| Krensavage asset management | 2.87M | 13.41% | $36.20M |
| Vanguard group | 2.30M | 10.77% | $36.30M |
| Deep track capital, lp | 1.96M | 9.15% | $24.72M |
| Blackrock | 1.85M | 8.72% | $23.96M |
| Millennium management | 882.10K | 4.13% | $11.14M |
| Acadian asset management | 880.02K | 4.12% | $11.10M |
| Commodore capital lp | 800.00K | 3.75% | $9.58M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Krensavage asset management | 2.87M | 14.16% | $36.20M |
| Commodore capital lp | 800.00K | 0.47% | $9.58M |
| Deep track capital, lp | 1.96M | 0.40% | $24.72M |
| Pharvision advisers | 35.85K | 0.24% | $429.08K |
| Opaleye management | 125.00K | 0.21% | $1.58M |
| Farallon capital management | 2.87M | 0.21% | $36.27M |
| Stempoint capital lp | 75.19K | 0.18% | $900.07K |
| Hillsdale investment management | 435.51K | 0.15% | $5.50M |
| Diadema partners lp | 64.95K | 0.14% | $820.34K |
| Persistent asset partners | 16.52K | 0.08% | $208.71K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | 800.00K | 0.47% | 800.00K |
| Vanguard group | 2.30M | 0.00% | 362.96K |
| Millennium management | 882.10K | 0.00% | 211.67K |
| Vanguard fiduciary trust | 175.86K | 0.00% | 175.86K |
| Citadel advisors | 262.53K | 0.00% | 169.38K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -1.04M |
| Armistice capital | - | - | -1.00M |
| Soleus capital management | - | - | -785.55K |
| Point72 asset management | - | - | -438.94K |
| Caligan partners lp | - | - | -184.83K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Commodore capital lp | 800.00K | 0.47% | 800.00K | $9.58M |
| Vanguard fiduciary trust | 175.86K | 0.00% | 175.86K | $2.22M |
| Stempoint capital lp | 75.19K | 0.18% | 75.19K | $900.07K |
| Cubist systematic strategies | 49.98K | 0.00% | 49.98K | $598.30K |
| Norges bank | 40.70K | - | 40.70K | $234.03K |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -1.00 |
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Innealta capital | -16.00 |
| Advisor group | -18.00 |
| Voisard asset management group | -28.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 129 | -1.53% | 26,744,972 | 1.35% | 125 | 1.48% | 70 | -14.63% | 32 | 23.08% |
| Dec 31, 2025 | 53 | -57.94% | 8,402,898 | -55.75% | 39 | 0.50% | 30 | -50.82% | 11 | -72.50% |
| Sep 30, 2025 | 47 | -53.00% | 5,407,827 | -68.64% | 25 | 0.39% | 20 | -55.56% | 17 | -55.26% |
| Jun 30, 2025 | 104 | -5.45% | 18,326,590 | -1.61% | 85 | 1.12% | 47 | -16.07% | 41 | 10.81% |
| Mar 31, 2025 | 5 | -95.33% | 2,149,611 | -88.86% | 10 | 0.12% | 2 | -96.61% | 1 | -96.55% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 629.60K | 2.95% | - |
| Vanguard Total Stock Mkt Idx Inv | 852.43K | 2.93% | - |
| iShares Russell 2000 ETF | 650.06K | 2.24% | 5.50K |
| BlackRock Health Sciences Opps Inv A | 492.00K | 1.69% | - |
| Columbia Small Cap Value I A | 271.73K | 1.28% | 3.30K |
| Hillsdale US Small Cap Eq Fund Srs A U$ | 352.70K | 1.22% | 352.70K |
| Vanguard Institutional Extnd Mkt Idx Tr | 301.21K | 1.04% | 2.12K |
| Vanguard Strategic Small-Cap Equity Inv | 280.93K | 0.97% | -36.31K |
| Columbia Small Cap Value I | 200.68K | 0.95% | 200.68K |
| Fidelity Small Cap Index | 265.86K | 0.92% | 1.85K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 05, 2025 | Capps Kathleen S. | See Remarks | Sell | $4.60K |
| Dec 05, 2025 | Trout Harry R. III | See Remarks | Sell | $7.71K |
| Dec 05, 2025 | Rottinghaus Scott T. | Chief Medical Officer | Sell | $11.36K |
| Dec 05, 2025 | Luu Brendan | Chief Business Officer | Sell | $19.84K |
| Dec 05, 2025 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | $29.97K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | 9 |
| 2025 Q3 | - | - |
| 2025 Q1 | 1 | - |
| 2024 Q4 | - | 6 |
ENTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools